macro

B. Riley raises Cleveland-Cliffs price target to $18 from $15

B. Riley Securities lifted its Cleveland-Cliffs price target to $18 from $15 and kept its Buy rating, according to Dow Jones Newswires.

the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →

what happened

B. Riley Securities raised its price target on Cleveland-Cliffs shares to $18 from $15 and maintained its Buy rating. Dow Jones Newswires, citing Benzinga data, reported the change, which was recorded on October 22, 2026 at 17:09 GMT.

A single brokerage adjusting its target is a routine market event. It reflects one analyst's valuation rather than any new decision announced by the company itself.

why it matters

A single price target change usually has limited impact on the broader market. For investors following steel stocks, such revisions show how professional analysts are reassessing the shares, but they do not by themselves alter the underlying fundamentals.

market impact

Cleveland-Cliffs shares: a higher target from one analyst reflects improved sentiment on the stock

tags

instruments

Cleveland-CliffsSteel stocks

sources

  1. Veradermics Price Target Raised to $204.00/Share From $170.00 by B. Riley Securities — Dow Jones Newswires, 22 October 2026 at 17:10 UTC
  2. Cleveland-Cliffs Price Target Raised to $18.00/Share From $15.00 by B. Riley Securities — Dow Jones Newswires, 22 October 2026 at 17:09 UTC

prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.

the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.

get stories in real time ↗